Elekta, SE0000163628

Elekta stock rises as CEO share purchase and short interest shape sentiment

Published on 09/16/2026 at 16:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elekta stock traded at SEK 51.45 on Nasdaq Stockholm as of September 15, 2026, with modest gains over recent sessions. A sizeable CEO share purchase and renewed short selling interest give investors fresh signals on the company.

Flatlay mit Aktienzertifikat, ISIN-Karte und medizinischen Utensilien auf weißem Untergrund
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte SE0000163628 zeigt Investment-Utensilien passend zur Branche von Elekta AB, Illustration mit AI erstellt.

Elekta stock (ISIN SE0000163628) traded at about SEK 51.45 on Nasdaq Stockholm as of September 15, 2026, with the shares up 2.8% over the last five trading days and 4.52% year to date, while still showing an 8.28% decline over the 52-week horizon per a Cboe Europe snapshot cited by Zonebourse on September 15, 2026.

CEO increases stake with multi-million-krona purchase

According to Ad-hoc-news on September 15, 2026, Elekta's chief executive bought approximately SEK 9.9 million worth of Elekta B shares, a move that has supported the share price around the SEK 51 mark.

The same overview based on Cboe Europe and Nasdaq Stockholm data indicates that Elekta B traded at SEK 51.45 as of September 15, 2026, compared with a 52-week performance showing a decline of 8.28%, underscoring that the CEO's purchase comes after a period of subdued longer-term returns.

Short seller returns and sector backdrop

Short interest has also re-emerged as a theme around Elekta stock. As MarketScreener reported on September 16, 2026, Millennium Capital Partners has returned as a disclosed short seller in Elekta according to the register of the Swedish Financial Supervisory Authority.

This renewed short position highlights that, despite the CEO's SEK 9.9 million purchase and modest recent share-price gains, some investors still see downside risk or valuation headwinds in Elekta's medical technology business.

Recent price performance and investor perspective

Per the Zonebourse snapshot referenced by Ad-hoc-news, Elekta B shares at SEK 51.45 on September 15, 2026 were up 2.8% over the last five trading days, illustrating a short-term recovery against a year-to-date gain of 4.52% and a negative 52-week performance of minus 8.28%.

For investors, the combination of insider buying on one side and the return of a disclosed short seller on the other side sets up a contrasting risk-reward picture, with Elekta stock currently trading below levels seen over much of the past year while the broader OMX Stockholm 30 index stood at 3,236.32 as of September 16, 2026 according to data compiled by KlickAnalytics.

Stock level and market context

With Elekta B quoted around SEK 51.45 on Nasdaq Stockholm as of September 15, 2026 based on Cboe Europe data, the stock remains below its level from much of the prior 52-week period, reflecting the minus 8.28% performance over that horizon even after the CEO's SEK 9.9 million share purchase.

Key data on Elekta stock

  • Company: Elekta AB
  • ISIN: SE0000163628
  • Ticker: EKTA B
  • Trading venue: Nasdaq Stockholm
  • Price (as of September 15, 2026, 13:20): 51.45 SEK
  • Sector / Industry: Health Care Equipment
  • Index membership: OMX Stockholm

More news and analyses on Elekta stock

Disclaimer...

en | SE0000163628 | ELEKTA | boerse | 70111293 | bgmi